Detalles de la búsqueda
1.
Concordance Between Tissue ALK Detection by Immunohistochemistry and Plasma ALK Detection by Next-Generation Sequencing in the Randomized Phase 3 ALEX Study in Patients With Treatment-Naive Advanced ALK-Positive NSCLC.
JTO Clin Res Rep
; 3(7): 100341, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35756755
2.
Driver Mutation Variant Allele Frequency in Circulating Tumor DNA and Association with Clinical Outcome in Patients with Non-Small Cell Lung Cancer and EGFR- and KRAS-Mutated Tumors.
J Mol Diagn
; 24(5): 543-553, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35301118
3.
Pre- and post-treatment blood-based genomic landscape of patients with ROS1 or NTRK fusion-positive solid tumours treated with entrectinib.
Mol Oncol
; 16(10): 2000-2014, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35338679
4.
Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin.
PLoS One
; 15(9): e0237802, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32976510
Resultados
1 -
4
de 4
1
Próxima >
>>